Evidence map›Paper›PMID 39225753›Full record

ArticleChembiochem : a European journal of chemical biology2024

Discovery and Heterologous Expression of Trilenodin, an Antimicrobial Lasso Peptide with a Unique Tri-Isoleucine Motif.

Conor Pulliam, Dan Xue, Andrew Campbell, Ethan Older, Jie Li

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Lasso peptides: A focus on therapeutic index.World journal of microbiology & biotechnology · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Conor PulliamDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina, 29208, United States.ORCID 0009-0009-1512-7956
Dan XueDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina, 29208, United States.
Andrew CampbellDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina, 29208, United States.
Ethan OlderDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina, 29208, United States.
Jie LiDepartment of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina, 29208, United States.ORCID 0000-0001-7977-6749

Funding

Accessing and Expanding Natural Products Chemical Diversity by Big-data Analysis and Biosynthetic InvestigationR35GM150565 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI Jie Li · 2023 to 2026
$1.3M
NIGMS NIH HHS R35 GM150565NIH HHS 1R35 GM150565
6 · The paper itself

Abstract

Lasso peptides are an increasingly relevant class of peptide natural products with diverse biological activities, intriguing physical properties, and unique chemical structures. Most characterized lasso peptides have been from Actinobacteria and Proteobacteria, despite bioinformatic analyses suggesting that other bacterial taxa, particularly those from Firmicutes, are rich in biosynthetic gene clusters (BGCs) encoding lasso peptides. Herein, we report the bioinformatic identification of a lasso peptide BGC from Paenibacillus taiwanensis DSM18679 which we termed pats. We used a bioinformatics-guided isolation approach and high-resolution tandem mass spectrometry (HRMS/MS) to isolate and subsequently characterize a new lasso peptide produced from the pats BGC, which we named trilenodin, after the tri-isoleucine motif present in its primary sequence. This tri-isoleucine motif is unique among currently characterized lasso peptides. We confirmed the connection between the pats BGC and trilenodin production by establishing the first Bacillus subtilis 168-based heterologous expression system for expressing Firmicutes lasso peptides. We finally determined that trilenodin exhibits potent antimicrobial activity against B. subtilis and Klebsiella pneumoniae, making trilenodin the first characterized biologically active lasso peptide from Firmicutes. Collectively, we demonstrate that bacteria from Firmicutes can serve as high-potential sources of chemically and biologically diverse lasso peptides.

Indexed as

Anti-Bacterial AgentsAmino Acid MotifsAmino Acid SequenceAntimicrobial PeptidesBacillus subtilisIsoleucineMicrobial Sensitivity TestsMultigene FamilyPaenibacillusAnti-Bacterial AgentsAntimicrobial PeptidesIsoleucineBioinformaticsBiological activityLasso peptidesMass spectrometryNatural products

Identifiers

PMID39225753
PMCPMC11664905

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.